MYC and cancer: With further study, DL78 can become a potent compound to study biological functions in nonmalignant cells, such as G1 exit and the antephase checkpoint, as well as in cancer cells such as in the context of Myc-driven mitotic abnormalities, given the phenotypes DL78 induces.